Adverse Reactions Associated with Parenteral Beta Agonists: Serum Potassium Changes
Abstract:Beta adrenergic agonists can lower serum potassium levels predominantly when they are administered by the parenteral route. Hypokalemia has been demonstrated with the use of albuterol given by the intramuscular, intravenous and subcutaneous (SC) routes as well as with SC epinephrine. The effect appears to be dose related. Certain patients might be at increased risk who are on medications that tend to lower potassium such as corticosteroids, theophylline, diuretics or digoxin. Further studies should be encouraged on the hypokalemic effect of all forms of beta agonists in view of their possible contribution toward arrhythmias and asthma deaths.
Document Type: Research Article
Publication date: September 1, 1987
More about this publication?
- Allergy and Asthma Proceedings is a peer reviewed publication dedicated to distributing timely scientific research regarding advancements in the knowledge and practice of allergy, asthma and immunology. Its primary readership consists of allergists and pulmonologists.
The goal of the Proceedings is to publish articles with a predominantly clinical focus which directly impact quality of care for patients with allergic disease and asthma.
Featured topics include asthma, rhinitis, sinusitis, food allergies, allergic skin diseases, diagnostic techniques, allergens, and treatment modalities. Published material includes peer-reviewed original research, clinical trials and review articles.
Articles marked "F" offer free full text for personal noncommercial use only.
The journal is indexed in Thomson Reuters Web of Science and Science Citation Index Expanded, plus the National Library of Medicine's PubMed service.
- Editorial Board
- Information for Authors
- Submit a Paper
- Information for Advertisers
- Reprint Requests
- Ingenta Connect is not responsible for the content or availability of external websites